
The study evaluated the use of liquid biopsies and cytology imprints as alternatives to immunohistochemistry for assessing PD-L1 expression in patients with non-small cell lung cancer (NSCLC). The results showed comparable PD-L1 expression between the different approaches, indicating that cytology imprints and liquid biopsies could be complementary to conventional immunohistochemistry for assessing PD-L1 expression. Cytology imprints and CTCs were also found to be useful for predicting PD-L1 positivity in cases where no tumor tissue is available.
Like
Save
Share